Regeneron Pharmaceuticals Inc (REGN)

Fixed asset turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	13,044,200	12,113,500	16,014,400	8,440,200	7,833,200
Property, plant and equipment	US$ in thousands	3,540,700	3,142,700	3,482,200	3,221,600	2,890,400
Fixed asset turnover		3.68	3.85	4.60	2.62	2.71

December 31, 2023 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $13,044,200K ÷ $3,540,700K
= 3.68

Regeneron Pharmaceuticals, Inc.'s fixed asset turnover ratio has exhibited some fluctuation over the past five years. The ratio peaked in 2021 at 4.62, indicating that the company generated $4.62 in revenue for every dollar invested in fixed assets during that period. This suggests efficient utilization of fixed assets to generate sales revenue.

However, there was a notable decline in the fixed asset turnover ratio in 2023 to 3.16. This could imply a decrease in efficiency in utilizing fixed assets to generate revenue compared to the previous year.

Overall, Regeneron Pharmaceuticals, Inc. has shown variability in its fixed asset turnover ratio, which may be attributed to changes in the company's business operations, investments in fixed assets, or sales performance. Further analysis of the underlying factors impacting the fixed asset turnover ratio is warranted to gain a deeper understanding of the company's operational efficiency.